Human pathology · 2018
Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sakata Junki, Yamana Keisuke, Yoshida Ryoji, Matsuoka Yuichiro, Kawahara Kenta, Arita Hidetaka, Nakashima Hikaru, Nagata Masashi, Hirosue Akiyuki, Kawaguchi Sho, Gohara Shunsuke, Nagao Yuka, Hiraki Akimitsu, Shinohara Masanori, Toya Ryo, Murakami Ryuji, Nakayama Hideki
Аннотация
Occult neck metastasis is an important prognostic factor in patients with tongue squamous cell carcinoma (TSCC) who are deemed clinically negative for neck metastasis. The purpose of this study was to identify predictive factors for occult neck metastasis arising from TSCC and to determine patient prognosis. Ninety-seven patients with cT2N0 TSCC who underwent surgical resection of their primary lesion as initial therapy were enrolled in this retrospective study. Cutoff values for depth of invasion (≥3.3 mm) and the tumor budding score (≥4) were determined using receiver operator characteristic analyses. Univariate and multivariate analyses revealed that a tumor budding score ≥4 is a significant independent predictive factor for the occurrence of occult neck metastasis, which in turn is a significant independent prognostic factor. When evaluating tumor budding, we demonstrated greater interobserver and intraobserver agreement when using immunohistochemical staining for cytokeratin AE1/AE3 than with hematoxylin and eosin staining (HE). We conclude that the evaluation of tumor budding is effective for identifying populations at high risk of occult neck metastasis, which will enable the planning of appropriate therapeutic strategies for patients with cT2N0 TSCC. Furthermore, cytokeratin staining is recommended over HE staining for simpler and more accurate evaluation of tumor budding.
Предметные рубрики MeSH
AdultAgedAged, 80 and overBiomarkers, TumorCell MovementFemaleGlossectomyHead and Neck NeoplasmsHumansImmunohistochemistryKeratinsMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingObserver VariationPredictive Value of TestsReproducibility of ResultsRetrospective StudiesSquamous Cell Carcinoma of Head and NeckStaining and LabelingTongue NeoplasmsTreatment Outcome